1![April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu](https://www.pdfsearch.io/img/903e9f241268e8b40cc63d13fc480827.jpg) | Add to Reading ListSource URL: www.herbal-ahp.orgLanguage: English - Date: 2018-04-13 15:31:29
|
---|
2![Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report](https://www.pdfsearch.io/img/c096360620fbeb48e19a39a31a1f9a03.jpg) | Add to Reading ListSource URL: microcapresearch.comLanguage: English - Date: 2016-08-30 19:31:41
|
---|
3![Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of](https://www.pdfsearch.io/img/faad6c59aff777cc95c642dd76ec7c41.jpg) | Add to Reading ListSource URL: www.warpdrivebio.comLanguage: English - Date: 2016-10-17 10:04:43
|
---|
4![Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and](https://www.pdfsearch.io/img/c19e7e42f4449ab01723e04bb30928aa.jpg) | Add to Reading ListSource URL: www.warpdrivebio.comLanguage: English - Date: 2018-03-13 18:27:46
|
---|
5![Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa](https://www.pdfsearch.io/img/c294da5e444a459a3fd393110e8460d0.jpg) | Add to Reading ListSource URL: www.daytrana.comLanguage: English - Date: 2016-02-25 12:18:23
|
---|
6![ANTISENSE THERAPEUTICS LIMITED AUDIT COMMITTEE CHARTER This Charter governs the operations of the Audit Committee (‘Committee’). The Committee shall review and reassess the Charter at least annually and obtain the ap ANTISENSE THERAPEUTICS LIMITED AUDIT COMMITTEE CHARTER This Charter governs the operations of the Audit Committee (‘Committee’). The Committee shall review and reassess the Charter at least annually and obtain the ap](https://www.pdfsearch.io/img/e5342beddc8fa6efe6b03b26f3d7ae5c.jpg) | Add to Reading ListSource URL: www.antisense.com.auLanguage: English - Date: 2017-01-23 18:20:22
|
---|
7![ANTISENSE THERAPEUTICS LIMITED COMMUNICATIONS POLICY Communications to Investors & Other Market Participants The purpose of this policy is to describe the process by which Antisense Therapeutics communicates with its inv ANTISENSE THERAPEUTICS LIMITED COMMUNICATIONS POLICY Communications to Investors & Other Market Participants The purpose of this policy is to describe the process by which Antisense Therapeutics communicates with its inv](https://www.pdfsearch.io/img/ec37ff6c42bf2f751db087afe95197c3.jpg) | Add to Reading ListSource URL: 43.229.63.250Language: English - Date: 2017-01-23 18:20:28
|
---|
8![UHC Expansion & Innovative Medicine Position Indonesian Perspective T. Bahdar Johan Hamid Deputy Chairman for Therapeutics Products, Narcotics, Psychotropics and Addictive Substances UHC Expansion & Innovative Medicine Position Indonesian Perspective T. Bahdar Johan Hamid Deputy Chairman for Therapeutics Products, Narcotics, Psychotropics and Addictive Substances](https://www.pdfsearch.io/img/d9d69d80691262ebbe27d1ead51d01a0.jpg) | Add to Reading ListSource URL: apac-asia.comLanguage: English - Date: 2016-05-24 02:04:55
|
---|
9![Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated I Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated I](https://www.pdfsearch.io/img/87244b0347e4e63eb4ad9b22b0913424.jpg) | Add to Reading ListSource URL: www.crescendobiologics.comLanguage: English - Date: 2018-05-31 07:22:36
|
---|
10![24th MarchMarket and Technology Update Antisense Therapeutics Limited (ASX:ANP or “the Company”) today provides an update on important developments that ANP regard as relevant to its late stage pipeline of ant 24th MarchMarket and Technology Update Antisense Therapeutics Limited (ASX:ANP or “the Company”) today provides an update on important developments that ANP regard as relevant to its late stage pipeline of ant](https://www.pdfsearch.io/img/8b7222d306f0b6db1181be4bf6fdac66.jpg) | Add to Reading ListSource URL: www.antisense.com.auLanguage: English - Date: 2017-03-26 19:47:46
|
---|